Entero Therapeutics Inc. (ENTO) Provides Business Update
Entero Therapeutics Inc. (ENTO) issued a business update covering recent developments.
🔍 Detailed Event Analysis:
AI Summary: On March 25, 2025, GridAI Technologies Corp. (f/k/a Entero Therapeutics, Inc.) and ImmunogenX, LLC (“Immuno LLC”) entered into a Rescission Agreement (the “Rescission Agreement’) by and among the Company and each of the individuals or entities (each a “Sharehol”).
📋 GridAI Technologies Corp. (ENTO) - Other Event
Filing Date: 2026-01-07
Accepted: 2026-01-07 16:05:41
Event Type: Other Event
Event Details:
🔍 Detailed Event Analysis:
AI Summary: On March 25, 2025, GridAI Technologies Corp. (f/k/a Entero Therapeutics, Inc.) and ImmunogenX, LLC (“Immuno LLC”) entered into a Rescission Agreement (the “Rescission Agreement’) by and among the Company and each of the individuals or entities (each a “Sharehol”).
Key Elements Identified:
💼 Business Developments:
No business developments data available.
Structured Data: